Dose Response Study of Transdermal Human Insulin in Patients
Clinical trial NCT05159453 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05159453
- Sponsor
- Transdermal Delivery Solutions Corp
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-09-02
- Primary completion
- 2027-10-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.